Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Lysmd2 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LYSMD2 mRNA] | CTD | PMID:31150632 | Lysmd2 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Lysmd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LYSMD2 mRNA | CTD | PMID:36331819 | Lysmd2 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of LYSMD2 mRNA | CTD | PMID:22206623 | Lysmd2 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Lysmd2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of LYSMD2 mRNA] | CTD | PMID:22206623 | Lysmd2 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of LYSMD2 mRNA | CTD | PMID:17555576 | Lysmd2 | Rat | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of LYSMD2 mRNA | CTD | PMID:17557909 | Lysmd2 | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of LYSMD2 mRNA | CTD | PMID:32145629 | Lysmd2 | Rat | 17beta-estradiol | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of LYSMD2 mRNA | CTD | PMID:31614463 | Lysmd2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Lysmd2 (Mus musculus) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether affects the expression of LYSMD2 mRNA | CTD | PMID:30294300 | Lysmd2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LYSMD2 mRNA | CTD | PMID:20106945 | Lysmd2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LYSMD2 mRNA | CTD | PMID:21570461 | Lysmd2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of LYSMD2 mRNA | CTD | PMID:22298810|PMID:34747641 | Lysmd2 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of LYSMD2 mRNA | CTD | PMID:21346803 | Lysmd2 | Rat | actinomycin D | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of LYSMD2 mRNA | CTD | PMID:38460933 | Lysmd2 | Rat | aflatoxin B1 | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of LYSMD2 mRNA | CTD | PMID:21641981 | Lysmd2 | Rat | aflatoxin B1 | decreases methylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of LYSMD2 gene | CTD | PMID:27153756 | Lysmd2 | Rat | all-trans-retinoic acid | decreases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of LYSMD2 mRNA | CTD | PMID:23724009 | Lysmd2 | Rat | antirheumatic drug | decreases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of LYSMD2 mRNA | CTD | PMID:24449571 | Lysmd2 | Rat | arsane | affects methylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of LYSMD2 gene | CTD | PMID:25304211 | Lysmd2 | Rat | arsenic atom | affects methylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of LYSMD2 gene | CTD | PMID:25304211 | Lysmd2 | Rat | benzo[a]pyrene | decreases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of LYSMD2 mRNA | CTD | PMID:19770486 | Lysmd2 | Rat | benzo[a]pyrene | decreases methylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of LYSMD2 exon | CTD | PMID:27901495 | Lysmd2 | Rat | benzo[a]pyrene | increases methylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of LYSMD2 promoter | CTD | PMID:27901495 | Lysmd2 | Rat | benzo[a]pyrene | affects methylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LYSMD2 5' UTR | CTD | PMID:27901495 | Lysmd2 | Rat | benzo[a]pyrene | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of LYSMD2 mRNA | CTD | PMID:22228805|PMID:22610609|PMID:32417428 | Lysmd2 | Rat | benzo[a]pyrene | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of LYSMD2 mRNA | CTD | PMID:21632981 | Lysmd2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LYSMD2 mRNA | CTD | PMID:25181051|PMID:32145629 | Lysmd2 | Rat | bisphenol A | increases methylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of LYSMD2 gene | CTD | PMID:31601247 | Lysmd2 | Rat | cadmium dichloride | decreases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of LYSMD2 mRNA | CTD | PMID:21457566 | Lysmd2 | Rat | caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of LYSMD2 mRNA | CTD | PMID:20864626 | Lysmd2 | Rat | cantharidin | decreases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Cantharidin results in decreased expression of LYSMD2 mRNA | CTD | PMID:36907384 | Lysmd2 | Rat | carbon nanotube | decreases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of LYSMD2 mRNA | CTD | PMID:25554681 | Lysmd2 | Rat | CGP 52608 | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to LYSMD2 gene] | CTD | PMID:28238834 | Lysmd2 | Rat | choline | multiple interactions | ISO | Lysmd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Lysmd2 | Rat | cisplatin | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of LYSMD2 mRNA | CTD | PMID:27392435 | Lysmd2 | Rat | cisplatin | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of LYSMD2 mRNA | CTD | PMID:27392435 | Lysmd2 | Rat | clothianidin | decreases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | clothianidin results in decreased expression of LYSMD2 mRNA | CTD | PMID:31626844 | Lysmd2 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of LYSMD2 mRNA | CTD | PMID:30556269 | Lysmd2 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of LYSMD2 mRNA | CTD | PMID:30556269 | Lysmd2 | Rat | coumarin | decreases phosphorylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of LYSMD2 protein | CTD | PMID:35688186 | Lysmd2 | Rat | cyclosporin A | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of LYSMD2 mRNA | CTD | PMID:20106945|PMID:21632981 | Lysmd2 | Rat | cyclosporin A | decreases methylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of LYSMD2 promoter | CTD | PMID:27989131 | Lysmd2 | Rat | cypermethrin | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | cypermethrin results in increased expression of LYSMD2 mRNA | CTD | PMID:29020013 | Lysmd2 | Rat | DDE | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of LYSMD2 mRNA | CTD | PMID:38568856 | Lysmd2 | Rat | dibenz[a,h]anthracene | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of LYSMD2 mRNA | CTD | PMID:26377693 | Lysmd2 | Rat | dichloroacetic acid | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of LYSMD2 mRNA | CTD | PMID:28962523 | Lysmd2 | Rat | dorsomorphin | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Lysmd2 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of LYSMD2 mRNA | CTD | PMID:24136188 | Lysmd2 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of LYSMD2 mRNA | CTD | PMID:24793618 | Lysmd2 | Rat | folic acid | multiple interactions | ISO | Lysmd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992|PMID:22206623 | Lysmd2 | Rat | FR900359 | increases phosphorylation | ISO | LYSMD2 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of LYSMD2 protein | CTD | PMID:37730182 | Lysmd2 | Rat | furan | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | furan results in increased expression of LYSMD2 mRNA | CTD | PMID:24183702 | Lysmd2 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of LYSMD2 mRNA | CTD | PMID:33387578 | Lysmd2 | Rat | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of LYSMD2 mRNA | CTD | PMID:24136188 | Lysmd2 | Rat | glycidyl methacrylate | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | glycidyl methacrylate results in increased expression of LYSMD2 protein | CTD | PMID:36641056 | Lysmd2 | Rat | L-methionine | multiple interactions | ISO | Lysmd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Lysmd2 | Rat | lead(0) | affects expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Lead affects the expression of LYSMD2 mRNA | CTD | PMID:28903495 | Lysmd2 | Rat | lipopolysaccharide | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LYSMD2 mRNA | CTD | PMID:35811015 | Lysmd2 | Rat | methoxyacetic acid | decreases expression | EXP | | 6480464 | methoxyacetic acid results in decreased expression of LYSMD2 mRNA | CTD | PMID:20864626 | Lysmd2 | Rat | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of LYSMD2 mRNA | CTD | PMID:20864626 | Lysmd2 | Rat | Monobutylphthalate | decreases expression | EXP | | 6480464 | monobutyl phthalate results in decreased expression of LYSMD2 mRNA | CTD | PMID:20864626 | Lysmd2 | Rat | N-nitrosodiethylamine | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of LYSMD2 mRNA | CTD | PMID:24535843 | Lysmd2 | Rat | nickel atom | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Nickel results in increased expression of LYSMD2 mRNA | CTD | PMID:24768652|PMID:25583101 | Lysmd2 | Rat | Nutlin-3 | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of LYSMD2 mRNA | CTD | PMID:38460933 | Lysmd2 | Rat | ozone | decreases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Ozone results in decreased expression of LYSMD2 mRNA | CTD | PMID:12763052 | Lysmd2 | Rat | ozone | multiple interactions | ISO | Lysmd2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... | CTD | PMID:34911549 | Lysmd2 | Rat | panobinostat | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | panobinostat results in increased expression of LYSMD2 mRNA | CTD | PMID:26272509 | Lysmd2 | Rat | panobinostat | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Lysmd2 | Rat | paracetamol | affects expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of LYSMD2 mRNA | CTD | PMID:17562736 | Lysmd2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of LYSMD2 mRNA | CTD | PMID:33387578 | Lysmd2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Lysmd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LYSMD2 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Lysmd2 | Rat | phenobarbital | affects expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of LYSMD2 mRNA | CTD | PMID:19136022 | Lysmd2 | Rat | pirinixic acid | affects expression | ISO | Lysmd2 (Mus musculus) | 6480464 | pirinixic acid affects the expression of LYSMD2 mRNA | CTD | PMID:19136022 | Lysmd2 | Rat | pirinixic acid | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of LYSMD2 mRNA | CTD | PMID:23811191 | Lysmd2 | Rat | propiconazole | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | propiconazole results in increased expression of LYSMD2 mRNA | CTD | PMID:21278054 | Lysmd2 | Rat | quercetin | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of LYSMD2 mRNA | CTD | PMID:21632981 | Lysmd2 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LYSMD2 mRNA | CTD | PMID:35811015 | Lysmd2 | Rat | SB 431542 | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Lysmd2 | Rat | sodium arsenite | decreases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of LYSMD2 mRNA | CTD | PMID:38568856 | Lysmd2 | Rat | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of LYSMD2 mRNA | CTD | PMID:25993096 | Lysmd2 | Rat | sodium fluoride | decreases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of LYSMD2 mRNA | CTD | PMID:27862939 | Lysmd2 | Rat | sulforaphane | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of LYSMD2 mRNA | CTD | PMID:31838189 | Lysmd2 | Rat | sunitinib | decreases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of LYSMD2 mRNA | CTD | PMID:31533062 | Lysmd2 | Rat | tamoxifen | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of LYSMD2 mRNA | CTD | PMID:25123088 | Lysmd2 | Rat | tamoxifen | affects expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Tamoxifen affects the expression of LYSMD2 mRNA | CTD | PMID:17555576 | Lysmd2 | Rat | temozolomide | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of LYSMD2 mRNA | CTD | PMID:31758290 | Lysmd2 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LYSMD2 mRNA] | CTD | PMID:31150632 | Lysmd2 | Rat | tetrachloromethane | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of LYSMD2 mRNA | CTD | PMID:31919559 | Lysmd2 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of LYSMD2 mRNA | CTD | PMID:31150632 | Lysmd2 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of LYSMD2 mRNA | CTD | PMID:23411599|PMID:34492290 | Lysmd2 | Rat | titanium dioxide | decreases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of LYSMD2 mRNA | CTD | PMID:29264374 | Lysmd2 | Rat | trichloroethene | increases expression | ISO | Lysmd2 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of LYSMD2 mRNA | CTD | PMID:25549359 | Lysmd2 | Rat | triphenyl phosphate | affects expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of LYSMD2 mRNA | CTD | PMID:37042841 | Lysmd2 | Rat | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of LYSMD2 mRNA | CTD | PMID:24136188 | Lysmd2 | Rat | valproic acid | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Lysmd2 | Rat | valproic acid | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of LYSMD2 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369 | Lysmd2 | Rat | vorinostat | multiple interactions | ISO | LYSMD2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Lysmd2 | Rat | vorinostat | increases expression | ISO | LYSMD2 (Homo sapiens) | 6480464 | vorinostat results in increased expression of LYSMD2 mRNA | CTD | PMID:26272509 | | |||||||||






















